Biotech Investment Analyst - Drug Asset & Company Assessment
Weekday AI United States
Pay not stated
The employer link is source-provided and is not live-verified by Applydra.
About the role
This role is for one of our clients
Compensation: $120 - $200 per hour
We are partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a biotech investment analyst (specialist-fund background) for a paid pilot, with the potential to continue as the work scales.
Requirements
Responsibilities
Create and critique rubrics that analyze commercial drugs and drug-development programs
Provide overall company and asset assessment — mechanism, clinical data, competitive position, and value drivers
Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions
Apply your assessment across the pilot's set of companies (~5–10)
Requirements
US-based biotech / healthcare investment analyst with a specialist-fund background
Familiarity with biotech/pharma development programs
Able to assess a drug asset and the company behind it end-to-end
5+ years evaluating biotech/pharma companies or assets
Engagement Details
Duration: Approximately 10–20 hours over a 1–2 week pilot
Remote — US-based
Why Participate
Help improve expert AI evaluation of drugs and drug-development programs
Recurring engagement for strong contributors
We consider all qualified applicants without regard to legally protected characteristics and provide reasonable accommodations upon request.
Posting text as published by Weekday AI.
The evidence behind this listing
- Workplace
- Remote Employer field
- Seniority
- Not established
- Employment type
- Not established
- Location as listed
- United States
Pay and work authorization
- Stated pay
- Not stated
- Visa sponsorship
- Not stated
- Security clearance
- Not established
- Citizenship
- Not established